.png){kind=icon}
返回期刊详情
European Urology
IF25.2
论文数18319
被引数36975
期刊论文 18319
发表时间
.png){kind=icon}
Reply to Nicholas Van As, Alison Tree, and Piet Ost’s Letter to the Editor, Drew T Bergman, Himanshu Nagar, and Timothy D McClure’s Letter to the Editor, and Richard J Bryant and Abhishek D Sharma’s Letter to the Editor re: Alexander Light, Max Peters, Archana Gopalakrishnan, et al. Oncological Outcomes Following Focal HIFU and Cryotherapy for Treatment of Nonmetastatic Prostate Cancer in the United Kingdom: An Updated Analysis of 3477 Patients from the Prospective HEAT and ICE Registries. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.05.007回复Nicholas Van As、Alison Tree和Piet Ost致编辑的信，Drew T Bergman、Himanshu Nagar和Timothy D McClure致编辑的信，以及Richard J Bryant和Abhishek D Sharma致编辑的信，关于：Alexander Light、Max Peters、Archana Gopalakrishnan等人。在英国使用局部高强度聚焦超声和冷冻疗法治疗非转移性前列腺癌后的肿瘤学结果：对来自前瞻性HEAT和ICE登记处的3477名患者进行的更新分析。欧洲泌尿学杂志。待发表。http://dx.doi.org/10.1016/j.eururo.2026.05.007.png)
European Urology.png)
.png)
分享.png)
收藏
European UrologyIF25.2
PREAI
分享收藏Re: Michael Baboudjian, Cosimo De Nunzio, Dean Elterman, et al. What is the Standard Comparator of Minimally Invasive Surgical Therapies (MIST) for Benign Prostatic Obstruction? Medical Versus Surgical Treatment. Eur Urol 2026;90:95–7关于米迦勒·巴布季安、科西莫·德·努齐奥、迪安·埃尔特曼等人：良性前列腺梗阻的微创外科疗法（MIST）的标准对照物是什么？药物治疗与手术治疗。欧洲泌尿学杂志 2026；90：95–7European Urology分享收藏
European UrologyIF25.2
PREAI
分享收藏Reply to Roberto Mario Scarpa’s Letter to the Editor: Sham or Active Control in MIST Trials? A False Methodological Dichotomy. re: Baboudjian M, Nunzio C, Elterman D, et al. What is the Standard Comparator of Minimally Invasive Surgical Therapies (MIST) for Benign Prostatic Obstruction? Medical Versus Surgical Treatment. Eur Urol. 2026 Aug;90(2):95-97.回复罗伯托·马里奥·斯卡帕致编辑的信：微创手术疗法（MIST）试验中的假对照或活性对照？一种错误的方法学二元论。回复：巴布季安 M，努尼奥 C，埃尔特曼 D 等。良性前列腺梗阻的微创手术疗法（MIST）的标准对照是什么？药物治疗与手术治疗。欧洲泌尿学杂志。2026年8月；90(2)：95-97。European Urology分享收藏
European UrologyIF25.2
PREAI
分享收藏In Response to “Five-Year Patient-reported Outcomes After SBRT for Prostate Cancer: A Benchmark for Radiotherapy, but How Far Across Modalities?” Pierre Blanchard, Chiara Sighinolfi, Mario Terlizzi, et al. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.07.023针对“前列腺癌SBRT治疗后五年患者报告结局：放疗领域的基准，但跨模态差距如何？”的回应：Pierre Blanchard, Chiara Sighinolfi, Mario Terlizzi, et al. Eur Urol. 即将发表. http://dx.doi.org/10.1016/j.eururo.2026.07.023European Urology分享收藏
European UrologyIF25.2
PREAI
分享收藏Re: Kari A. O. Tikkinen, Maura Marcucci, Alex L. E. Halme, et al. Safety and Efficacy of Tranexamic Acid in Urologic Surgery: Results from the International, Randomized, Placebo-controlled POISE-3 Trial. Eur Urol 2026;90:140–9致：Kari A. O. Tikkinen, Maura Marcucci, Alex L. E. Halme 等人。曲安奈德在泌尿外科手术中的安全性与有效性：来自国际、随机、安慰剂对照的POISE-3试验结果。欧洲泌尿学杂志，2026年，第90卷，第140-149页European Urology分享收藏
European UrologyIF25.2
PREAI
分享收藏Re: Arie Parnham, Maarten Albersen, Benjamin Ayres, et al. European Association of Urology and American Society of Clinical Oncology Guidelines on Penile Cancer: A Summary of the 2026 Guidelines Update. Eur Urol 2026;90:60–71关于Arie Parnham、Maarten Albersen、Benjamin Ayres等人。欧洲泌尿外科学会和美国临床肿瘤学会关于阴茎癌指南：2026年指南更新的总结。Eur Urol 2026;90:60–71European Urology分享收藏
European UrologyIF25.2
PREAI
分享收藏Reply to Dachun Jin, Chi-Fai Ng, and Peter Ka-Fung Chiu’s Letter to the Editor re: Bi-Ming He, Keqin Zhang, Zhien Zhou, et al. Cognitive Versus Software-based Fusion Targeted Biopsy for the Diagnosis of Clinically Significant Prostate Cancer: A Multicenter, Randomized, Noninferiority Trial (IMAGINATION). Eur Urol. In press. https://doi.org/10.1016/j.eururo.2026.06.020回复金大春、Ng Chi-Fai和Peter Ka-Fung Chiu致编辑的信：关于何碧明、张克勤、周志恩等人的论文“认知与软件融合靶向活检诊断临床显著性前列腺癌：一项多中心、随机、非劣效性试验（IMAGINATION）”。欧洲泌尿外科杂志。待发表。https://doi.org/10.1016/j.eururo.2026.06.020European Urology分享收藏
European UrologyIF25.2
PREAI
分享收藏Reply to Sho Todo, Keiichiro Kitahama, and Kentaro Inamura's Letter to the Editor re: Wenxin Xu, Brian I. Rini, Laurence Albiges, et al. Comprehensive Genomic and Transcriptomic Characterization of Matched Primary and Recurrent Tumors in High-risk Localized Renal Cell Carcinoma. Eur Urol. 2026 Apr 25:S0302-2838(26)02060-9回复Todo Sho、Kitahama Keiichiro和Inamura Kentaro致编辑的信，关于：徐文欣、Brian I. Rini、Laurence Albiges等人关于高风险局限性肾细胞癌匹配的原发和复发肿瘤的全面基因组学和转录组学特征。欧洲泌尿学杂志。2026年4月25日：S0302-2838(26)02060-9European Urology分享收藏
European UrologyIF25.2
PREAI
分享收藏Re: Aldo Brassetti, Gabriele Tuderti, Umberto Anceschi, et al. Sutureless Purely Off-clamp Robotic Partial Nephrectomy: Evidence from a Randomized Controlled Noninferiority Trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.04.019阿尔多·布拉塞蒂、加布里埃莱·图德蒂、乌姆贝托·安切斯基等人。无需缝合、完全离断机器人辅助部分肾切除术：一项随机对照非劣效性试验的证据。欧洲泌尿学杂志。待发表。http://dx.doi.org/10.1016/j.eururo.2026.04.019European Urology分享收藏
European UrologyIF25.2
PREAI
分享收藏Re: Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, et al. EAU–EANM–ESTRO–ESUR–ISUP–SIOG Guidelines on Prostate Cancer—2026 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2026.04.013Philip Cornford，Roderick C.N. van den Bergh，Erik Briers等人。EAU–EANM–ESTRO–ESUR–ISUP–SIOG前列腺癌指南—2026年更新。第一部分：筛查、诊断和根治性局部治疗。欧洲泌尿外科杂志。待发表。https://doi.org/10.1016/j.eururo.2026.04.013European Urology分享收藏
European UrologyIF25.2
PREAI
分享收藏Re: Sobia Khan, Nathan Papa, Andrew Kneebone, et al. Prospective Comparison of 64Copper [64Cu]SAR-bisPSMA vs 68Gallium [68Ga] PSMA-11 PET/CT for Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy (Co-PSMA Trial). Eur Urol 2026;89:512–20关于Sobia Khan、Nathan Papa、Andrew Kneebone等人. 前瞻性比较64铜 [64Cu]SAR-bisPSMA与68镓 [68Ga] PSMA-11 PET/CT在根治性前列腺切除术后前列腺癌生化复发中的应用（Co-PSMA试验）. Eur Urol 2026;89:512–20European Urology分享收藏
European UrologyIF25.2
PREAI
分享收藏